Leveraging bioelectronic assays for cell-based therapy
Cell-based immunotherapies are revolutionising medicine; and, although they are relatively new, they are poised to disrupt the biomedical industry, reports Dr Jim Ross, Chief Technology Officer and cofounder, Axion Biosystems